• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紧密连接蛋白-18与表皮生长因子受体/细胞外信号调节激酶信号通路相互作用,促进胆管癌的恶性潜能。

Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer.

作者信息

Takasawa Kumi, Takasawa Akira, Osanai Makoto, Aoyama Tomoyuki, Ono Yusuke, Kono Tsuyoshi, Hirohashi Yoshihiko, Murata Masaki, Sawada Norimasa

机构信息

Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.

出版信息

Cancer Lett. 2017 Sep 10;403:66-73. doi: 10.1016/j.canlet.2017.05.033. Epub 2017 Jun 15.

DOI:10.1016/j.canlet.2017.05.033
PMID:28624624
Abstract

Our recent work revealed that elevated expression of claudin-18 is involved in bile duct neoplasia. In the present study, we found that wound generation of a cell sheet de novo induced claudin-18 expression in its leading edge, coincident with high mitotic activity. We also found that the suppression of claudin-18 expression significantly reduced cell growth and invasiveness of bile duct cancer cell lines and tumorigenicity in vivo. In addition, an antibody specific to an extracellular loop of claudin-18 showed similar effects on the cells such as cell proliferation. Interestingly, treatment with epidermal growth factor (EGF) and overexpression of RAS oncogene induced claudin-18 expression by activation of extracellular signal-related kinase (ERK)1/2. Furthermore, enhanced claudin-18 expression activated ERK1/2. These findings provide evidence for an oncogenic property of claudin-18 in bile duct carcinoma cells via modulation of EGFR/ERK signaling, indicating that claudin-18 is a possible therapeutic target for this malignancy.

摘要

我们最近的研究表明,紧密连接蛋白-18(claudin-18)表达升高与胆管肿瘤形成有关。在本研究中,我们发现细胞片层的新生伤口可在其前沿诱导紧密连接蛋白-18表达,这与高有丝分裂活性同时出现。我们还发现,抑制紧密连接蛋白-18表达可显著降低胆管癌细胞系的细胞生长和侵袭能力以及体内致瘤性。此外,一种针对紧密连接蛋白-18细胞外环的特异性抗体对细胞增殖等方面表现出类似作用。有趣的是,表皮生长因子(EGF)处理和RAS癌基因过表达通过激活细胞外信号调节激酶(ERK)1/2诱导紧密连接蛋白-18表达。此外,增强的紧密连接蛋白-18表达激活了ERK1/2。这些发现为紧密连接蛋白-18通过调节表皮生长因子受体(EGFR)/ERK信号通路在胆管癌细胞中的致癌特性提供了证据,表明紧密连接蛋白-18可能是这种恶性肿瘤的治疗靶点。

相似文献

1
Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer.紧密连接蛋白-18与表皮生长因子受体/细胞外信号调节激酶信号通路相互作用,促进胆管癌的恶性潜能。
Cancer Lett. 2017 Sep 10;403:66-73. doi: 10.1016/j.canlet.2017.05.033. Epub 2017 Jun 15.
2
Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.表皮生长因子受体/丝裂原活化蛋白激酶/细胞外信号调节激酶/c-Fos信号通路使肺腺癌A549细胞中紧密连接蛋白2表达增加。
Biochim Biophys Acta. 2012 Jun;1823(6):1110-8. doi: 10.1016/j.bbamcr.2012.04.005. Epub 2012 Apr 24.
3
MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.微小RNA-133b通过靶向表皮生长因子受体使Akt和Erk1/2失活,从而抑制卵巢癌细胞的增殖和侵袭。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):10605-14. eCollection 2015.
4
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.催乳素调节人T47D乳腺癌细胞中表皮生长因子受体的磷酸化、信号传导和运输。
Oncogene. 2006 Dec 7;25(58):7565-76. doi: 10.1038/sj.onc.1209740. Epub 2006 Jun 19.
5
α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.α-硫辛酸通过Grb2介导的表皮生长因子受体下调抑制人肺癌细胞增殖。
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):325-331. doi: 10.1016/j.bbrc.2017.10.030. Epub 2017 Oct 7.
6
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.自分泌WNT信号通过经典WNT途径和表皮生长因子受体(EGFR)反式激活促进乳腺癌细胞增殖。
Breast Cancer Res. 2007;9(5):R63. doi: 10.1186/bcr1769.
7
Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.葡萄籽提取物抑制表皮生长因子(EGF)诱导的和组成型激活的促有丝分裂信号传导,但激活人前列腺癌DU145细胞中的JNK:在抗增殖和凋亡中的可能作用。
Oncogene. 2003 Mar 6;22(9):1302-16. doi: 10.1038/sj.onc.1206265.
8
Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling.Claudin-3 过表达增加结直肠癌细胞的恶性潜能:ERK1/2 和 PI3K-Akt 作为 EGFR 信号转导调节剂的作用。
PLoS One. 2013 Sep 19;8(9):e74994. doi: 10.1371/journal.pone.0074994. eCollection 2013.
9
Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.在胰腺癌细胞中,表皮生长因子受体向丝裂原活化蛋白激酶途径的信号传导绕过了Ras。
Pancreas. 2016 Feb;45(2):286-92. doi: 10.1097/MPA.0000000000000379.
10
Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.SNT-2/FRS2β/FRS3对接/衔接蛋白在表皮生长因子受体酪氨酸激酶信号通路中负调控的独特作用
Oncogene. 2006 Oct 19;25(49):6457-66. doi: 10.1038/sj.onc.1209656. Epub 2006 May 15.

引用本文的文献

1
Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond.针对胃癌非致癌驱动因子的新证据:Claudin18.2及其他。
Ther Adv Med Oncol. 2025 Jun 16;17:17588359251344804. doi: 10.1177/17588359251344804. eCollection 2025.
2
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma.紧密连接蛋白18.2:胆管癌潜在的纳米治疗靶点
Front Pharmacol. 2025 Mar 26;16:1559558. doi: 10.3389/fphar.2025.1559558. eCollection 2025.
3
Pancreatic Cancer: Pathogenesis and Clinical Studies.胰腺癌:发病机制与临床研究
MedComm (2020). 2025 Apr 2;6(4):e70162. doi: 10.1002/mco2.70162. eCollection 2025 Apr.
4
Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma.Claudin-18.2在肝内胆管癌中的预后作用
Virchows Arch. 2025 Mar 28. doi: 10.1007/s00428-025-04081-x.
5
Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers.紧密连接蛋白:从上皮完整性的守护者到肝胰胆管癌的潜在靶点
Front Oncol. 2024 Sep 26;14:1454882. doi: 10.3389/fonc.2024.1454882. eCollection 2024.
6
Multilayered proteomics reveals that JAM-A promotes breast cancer progression via regulation of amino acid transporter LAT1.多层次蛋白质组学揭示,JAM-A 通过调节氨基酸转运蛋白 LAT1 促进乳腺癌的进展。
Cancer Sci. 2024 Sep;115(9):3153-3168. doi: 10.1111/cas.16259. Epub 2024 Jun 29.
7
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer.zolbetuximab 用于胃癌治疗的临床前发现和开发。
Expert Opin Drug Discov. 2024 Aug;19(8):873-886. doi: 10.1080/17460441.2024.2370332. Epub 2024 Jun 26.
8
Progress of Clinical Studies Targeting Claudin18.2 for the Treatment of Gastric Cancer.靶向Claudin18.2治疗胃癌的临床研究进展
Dig Dis Sci. 2024 Jul;69(7):2631-2647. doi: 10.1007/s10620-024-08435-4. Epub 2024 May 20.
9
Claudins in Cancer: A Current and Future Therapeutic Target.紧密连接蛋白在癌症中的作用:当前和未来的治疗靶点。
Int J Mol Sci. 2024 Apr 24;25(9):4634. doi: 10.3390/ijms25094634.
10
Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer.黑马靶点Claudin18.2为胰腺癌开辟新战场。
Front Oncol. 2024 Mar 6;14:1371421. doi: 10.3389/fonc.2024.1371421. eCollection 2024.